Comments on:

RI gets $1.2M in diabetes drug settlement

Back to the article » |
PROVIDENCE, R.I. (AP) — Rhode Island is getting about $1.2 million to settle claims that British drug maker GlaxoSmithKline deceptively promoted the diabetes drug Avandia. The payment is part of a $90 million settlement between GlaxoSmithKline and attorneys general from 38 different states. Attorney General Peter Kilmartin and colleagues claim the company misrepresented Avandia's cardiovascular...

To learn more about commenting on WashingtonExaminer.com and our community guidelines, please see our comments FAQ.